MEDSHAPE, INC. – Trademark Portfolio

Entity Type: 03

MEDSHAPE, INC. holds 35 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 33 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 19 trademarks are registered and 2 are pending. Notable registered marks include ALTERA, ECLIPSE, MORPHIX, DYNACLIP, and DYNANAIL. The owner is based in Atlanta, GA.

Suite 440

1575 Northside Drive, NW

Atlanta, GA 30318

35 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (35 results)

Trademark Classifications

MEDSHAPE, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (33 filings)

Surgical, medical, dental and veterinary apparatus and instruments

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does MEDSHAPE, INC. have?

MEDSHAPE, INC. has 35 U.S. trademarks filed with the USPTO. Of these, 19 registered, 2 pending, 11 abandoned, 3 cancelled.

What trademark classes does MEDSHAPE, INC. file in?

MEDSHAPE, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 1 (Chemicals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are MEDSHAPE, INC.'s most well-known trademarks?

MEDSHAPE, INC.'s registered trademark portfolio includes well-known marks such as ALTERA, ECLIPSE, MORPHIX, DYNACLIP, and DYNANAIL. These are among 19 currently registered trademarks in the portfolio.

What is MEDSHAPE, INC.'s trademark registration success rate?

MEDSHAPE, INC. has a 58% trademark registration rate, with 19 out of 33 resolved applications resulting in successful registration. Currently, 2 applications are pending review.